Phase II trial to investigate efficacy and safety of bendamustine, dexamethasone and thalidomide in relapsed or refractory multiple myeloma patients after treatment with lenalidomide and bortezomib
- PMID: 30478966
- DOI: 10.1111/bjh.15645
Phase II trial to investigate efficacy and safety of bendamustine, dexamethasone and thalidomide in relapsed or refractory multiple myeloma patients after treatment with lenalidomide and bortezomib
Keywords: bendamustine; dexametasone; myeloma; refractory; thalidomide.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical